ICCT — Icoreconnect Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $1.27m
- $6.94m
- $7.99m
Annual income statement for Icoreconnect, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.09 | 1.01 | 2.12 | 4.96 | 7.99 |
| Cost of Revenue | |||||
| Gross Profit | 0.64 | 0.709 | 1.11 | 3.38 | 5.74 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.31 | 3.7 | 5.33 | 7.91 | 12.8 |
| Operating Profit | -3.22 | -2.68 | -3.2 | -2.96 | -4.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.19 | -2.98 | -3.49 | -4.96 | -6.08 |
| Net Income After Taxes | -5.19 | -2.98 | -3.49 | -4.96 | -6.08 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.19 | -2.98 | -3.49 | -4.96 | -6.08 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.19 | -2.98 | -3.49 | -4.96 | -6.08 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.116 | -0.063 | -0.046 | -0.036 | -0.035 |